DK0791056T3 - Lipidopspaltende enzymkompleks - Google Patents

Lipidopspaltende enzymkompleks

Info

Publication number
DK0791056T3
DK0791056T3 DK95937058T DK95937058T DK0791056T3 DK 0791056 T3 DK0791056 T3 DK 0791056T3 DK 95937058 T DK95937058 T DK 95937058T DK 95937058 T DK95937058 T DK 95937058T DK 0791056 T3 DK0791056 T3 DK 0791056T3
Authority
DK
Denmark
Prior art keywords
enzyme
substrates
enzyme complex
cleavage enzyme
disclosed
Prior art date
Application number
DK95937058T
Other languages
Danish (da)
English (en)
Inventor
Hans-Georg Opitz
Harald Zilch
Dieter Herrmann
Original Assignee
Heidelberg Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19518278A external-priority patent/DE19518278A1/de
Application filed by Heidelberg Pharma Gmbh filed Critical Heidelberg Pharma Gmbh
Application granted granted Critical
Publication of DK0791056T3 publication Critical patent/DK0791056T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK95937058T 1994-11-12 1995-11-09 Lipidopspaltende enzymkompleks DK0791056T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4440472 1994-11-12
DE19518278A DE19518278A1 (de) 1994-11-12 1995-05-18 Lipidspaltendes Enzym
PCT/EP1995/004414 WO1996015234A2 (de) 1994-11-12 1995-11-09 Lipidspaltendes enzym

Publications (1)

Publication Number Publication Date
DK0791056T3 true DK0791056T3 (da) 2005-07-04

Family

ID=25941931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937058T DK0791056T3 (da) 1994-11-12 1995-11-09 Lipidopspaltende enzymkompleks

Country Status (12)

Country Link
EP (1) EP0791056B1 (pt)
JP (2) JP3681005B2 (pt)
AT (1) ATE292173T1 (pt)
AU (1) AU711367B2 (pt)
CA (1) CA2204908A1 (pt)
DE (1) DE59510996D1 (pt)
DK (1) DK0791056T3 (pt)
ES (1) ES2239761T3 (pt)
HU (1) HUT77486A (pt)
NZ (1) NZ295682A (pt)
PT (1) PT791056E (pt)
WO (1) WO1996015234A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50102334D1 (de) 2000-03-31 2004-06-24 Stockhausen Chem Fab Gmbh Pulverförmige, an der oberfläche vernetzte polymerisate
EP1460082A1 (en) * 2003-03-19 2004-09-22 Heidelberg Pharma Holding GmbH Phospholipid esters of clofarabine derivatives
WO2008052722A2 (en) * 2006-11-02 2008-05-08 Heidelberg Pharma Ag Use of ribavirin-conjugates as an anti-viral drug
EP2070938A1 (en) * 2007-12-13 2009-06-17 Heidelberg Pharma AG Clofarabine dietherphospholipid derivatives
WO2022258614A1 (en) * 2021-06-07 2022-12-15 Campbell Farida Hanna Multi-virus anti-infectivity and pro-immunity assembly

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4026265A1 (de) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
DE4402492A1 (de) * 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Herstellung von unsymmetrischen Phosphorsäurediestern

Also Published As

Publication number Publication date
EP0791056A2 (de) 1997-08-27
AU711367B2 (en) 1999-10-14
ES2239761T3 (es) 2005-10-01
JPH10508498A (ja) 1998-08-25
JP3681005B2 (ja) 2005-08-10
JP2005095178A (ja) 2005-04-14
HUT77486A (hu) 1998-05-28
AU3927895A (en) 1996-06-06
EP0791056B1 (de) 2005-03-30
ATE292173T1 (de) 2005-04-15
CA2204908A1 (en) 1996-05-23
NZ295682A (en) 1999-09-29
WO1996015234A2 (de) 1996-05-23
WO1996015234A3 (de) 1996-06-20
PT791056E (pt) 2005-08-31
DE59510996D1 (de) 2005-05-04

Similar Documents

Publication Publication Date Title
Ortega‐Gómez et al. Resolution of inflammation: an integrated view
Mizel et al. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).
Unanue et al. Regulation of immunity and inflammation by mediators from macrophages.
Satta et al. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide
Ward Leukotactic factors in health and disease
McCARTHY et al. Mediation of macrophage collagenase production by 3'-5'cyclic adenosine monophosphate.
Sadique et al. The anti-inflammatory activity of Enicostemma littorale and Mollugo cerviana
DE69334224D1 (de) Lymphotoxin-beta, lymphotoxin-beta komplexe, pharmazeutische zubereitungen und therapeutische verwendungen davon
ATE218365T1 (de) Stabilisierte mischung auf fibrinogenbasis
DK0607118T3 (da) System til administrering af phospholipid
Smith et al. Pharmacological modulation of chemotactic factor-elicited release of granule-associated enzymes from human neutrophils: Effects of prostaglandins, nonsteroid anti-inflammatory agents and corticosteroids
DK0791056T3 (da) Lipidopspaltende enzymkompleks
Class et al. Histone H1 suppresses tumor growth of leukemia cells in vitro, ex vivo and in an animal model suggesting extracellular functions of histones
Barnes Platelets in glomerular disease
Eisen Plasma kinins in synovial exudates
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
Dessaint et al. Catheptic Carboxypeptidase B as A Major Componekt in “T-Cell Activating Factor” of Macrophages
Ragsdale et al. Characteristics of fibrinolytic enzyme release from human monocytes.
ES2145284T3 (es) Derivados del acido dioxo-tiopirano-piridin-carboxilico y su uso como farmacos.
Schwartz Enzyme mediators of mast cells and basophils
De Jong et al. The inter‐relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene‐B4—an immunohistochemical study
SE8601563D0 (sv) Matrismaterial, forfarande for framstellning derav och anvendning derav
BR9611588A (pt) Utilização da flupirtina na profilaxia e terapia de doenças associadoas com danos ao sistema celular hematopoiético
Harris et al. Cellular control of collagen breakdown in rheumatoid arthritis
Schwartz et al. The effect of tryptase from human mast cells on human prekallikrein